Advertisement

Journal of Neurology

, Volume 241, Issue 9, pp 567–569 | Cite as

Valproate encephalopathy and hypocarnitinaemia in diabetic patients

  • Lea Averbuch-Heller
  • Tamir Ben-Hur
  • Avinoam Reches
Original Communication

Abstract

Two patients with epilepsy and diabetes mellitus developed encephalopathy while on valproate monotherapy. Low plasma carnitine levels were found. Discontinuation of valproate was followed by clinical recovery and normalization of carnitine levels. Both valproate treatment and diabetes mellitus may contribute to secondary carnitine deficiency, with resultant encephalopathy. Thus, diabetic patients may be at increased risk of developing valproate encephalopathy associated with hypocarnitinaemia.

Key words

Valproate Diabetes Hypocarnitinaemia Encephalopathy 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bohan TP, Millington DS, Roe CR, et al (1984) Valproyl carnitine: a novel metabolite of valproic acid. Ann Neurol 16:39Google Scholar
  2. 2.
    Coulter DL (1991) Carnitine, valproate and toxicity. J Child Neurol 6:7–14Google Scholar
  3. 3.
    Dreifuss FE, Langer DH (1988) Side effects of valproate. Am J Med 84: [Suppl IA]:34–41Google Scholar
  4. 4.
    Jones GL, Matsuo F, Baringer JR, Reichert WH (1990) Valproic acid-associated encephalopathy. West J Med 153:199–202Google Scholar
  5. 5.
    Murakami K, Sugimoto T, Nishida N, et al (1992) Abnormal metabolism of carnitine and valproate in a case of acute encepbalopathy during chronic valproate therapy. Brain Dev 14:178–181Google Scholar
  6. 6.
    Ohtani Y, Endo F, Matsuda J (1982) Carnitine deficiency and hyperammonemia associated with valproic acid therapy. J Pediatr 101:782–785Google Scholar
  7. 7.
    Schafer J, Reichmann H (1990) Subnormal carnitine levels and their correction in artificially fed patients from a neurological intensive care unit. J Neurol 237:213–215Google Scholar
  8. 8.
    Triggs WJ, Bohan TP, Lin S-N, Willmore J (1990) Valproate-induced coma with ketosis and carnitine insufficiency. Arch Neurol 47:1131–1133Google Scholar
  9. 9.
    Trimble MR, Thompson PJ (1984) Sodium valproate and cognitive function. Epilepsia 25 [Suppl 1]:60–64Google Scholar
  10. 10.
    Verbiest HBC, Straver JS, Colombo JP, Vijver JCM van der, Woerkom TCAM van (1992) Carbamyl phosphate synthetase-1 deficiency discovered after valproic-acid induced coma. Acta Neurol Scand 86:275–279Google Scholar
  11. 11.
    Winter SC, Szabo-Aczel S, Curry J, et al (1987) Plasma carnitine deficiency. Clinical observations in 51 pediatric patients. Am J Dis Child 141:660–665Google Scholar
  12. 12.
    Winter SC, Simon M, Zorn EM, et al (1989) Relative carnitine insufficiency in children with type I diabetes mellitus. Am J Dis Child 143:1337–1339Google Scholar

Copyright information

© Springer-Verlag 1994

Authors and Affiliations

  • Lea Averbuch-Heller
    • 1
  • Tamir Ben-Hur
    • 1
  • Avinoam Reches
    • 1
  1. 1.Department of NeurologyHadassah University Hospital and Hebrew University, Hadassah Medical SchoolJerusalemIsrael

Personalised recommendations